Creating Hope Act and Tropical Disease Vouchers Issued and Exercised Please see the CHA PRV vouchers table.
Rare Pediatric Disease Priority Review Voucher Fee See Federal Register Notice.
FDA approves Cholbam to treat rare bile acid synthesis disorders For Immediate Release March 17, 2015 Today the U.S. Food and Drug read more →
Kids v Cancer Congratulates United Therapeutics on Receiving Priority Review Voucher Through the Creating Hope Act WASHINGTON, March 10, 2015 /PRNewswire-USNewswire/ — read more →
FDA approves first therapy for high-risk neuroblastoma For Immediate Release March 10, 2015 The U.S. Food and Drug Administration today approved Unituxin read more →
FDA NEWS RELEASE For Immediate Release: Feb. 14, 2014 Media Inquiries: Andrea Fischer, 301-796-0393, firstname.lastname@example.org Consumer Inquiries: 888-INFO-FDA FDA approves Vimizim to read more →